首都医科大学学报 ›› 2022, Vol. 43 ›› Issue (4): 622-629.doi: 10.3969/j.issn.1006-7795.2022.04.017

• 基础研究 • 上一篇    下一篇

1型糖尿病伴认知功能损伤小鼠脑组织肠道菌群代谢物的改变

安宇, 边南南, 丁小雨, 常晓娜, 刘佳, 王广*   

  1. 首都医科大学附属北京朝阳医院内分泌科,北京 100020
  • 收稿日期:2022-02-18 出版日期:2022-08-21 发布日期:2022-10-28
  • 基金资助:
    国家自然科学基金青年项目(82103811),首都医科大学附属北京朝阳医院金种子科研基金(CYJZ202102),中国科协第六届青年人才托举工程项目(2020QNRC001)。

Dysregulated microbial metabolites in brain of mice with type 1 diabetes mellitus-induced cognitive impairment

An Yu, Bian Nannan, Ding Xiaoyu, Chang Xiaona, Liu Jia, Wang Guang*   

  1. Department of Endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
  • Received:2022-02-18 Online:2022-08-21 Published:2022-10-28
  • Contact: *E-mail:drwg6688@aliyun.com
  • Supported by:
    This study was supported by National Natural Science Foundation of China (82103811),Golden Seed Program of Beijing Chaoyang Hospital (CYJZ202102),Young Elite Scientist Sponsorship Program by Cast (2020QNRC001).

摘要: 目的 探讨在发生认知功能损伤的1型糖尿病(type 1 diabetes mellitus,T1DM)小鼠脑组织中肠道菌群代谢物的变化。方法 选取20只6周龄C57BL/6小鼠,适应性喂养1周后采用数字表法随机分为对照组(Control组,n=10)和1型糖尿病模型组(DM组,n=10)进行处理。采用链脲佐菌素(streptozotocin,STZ)诱导T1DM小鼠,造模成功8周后进行Morris水迷宫检测,随后收集小鼠脑组织采用宏代谢组学检测肠道菌群代谢产物,并分析差异代谢物以及代谢通路。结果 STZ腹腔注射后8周DM组小鼠空间学习和记忆能力明显受损,表现为Morris水迷宫中逃避潜伏期显著增加(P<0.001),平均游泳距离显著增加(P=0.001),目的象限所在时间(P=0.043)和穿越平台次数显著减少(P=0.004)。采用宏代谢组学鉴定了脑组织中123种肠道菌群代谢物并发现了谷氨酰胺(Log2FC=0.262,P=0.002)、酒石酸(Log2FC=0.847,P=0.017)、乳酸(Log2FC=0.326,P=0.002)和间氨基苯甲酸(Log2FC=1.028,P=0.046)、3-氨基异丁酸(Log2FC=-1.466,P=0.049)、葡萄糖酸内酯(Log2FC=-0.796,P=0.043)和苏糖酸(Log2FC=-0.310,P=0.042)、吲哚乳酸(Log2FC=-1.252,P=0.030)、酮亮氨酸(Log2FC=-0.922,P=0.040)、3-羟基丁酸(Log2FC=-0.372,P=0.009)以及肉豆蔻酸(Log2FC=-0.563,P=0.035)11种显著差异代谢物,涉及14个主要相关代谢通路,包括嘧啶代谢、氨基酸代谢、糖代谢、短链脂肪酸代谢等。结论 DM小鼠脑组织中多种肠道菌群代谢物水平发生显著变化,靶向肠道菌群及其相关代谢通路有望成为治疗T1DM诱导的认知功能障碍的有效策略。

关键词: 1型糖尿病, 认知功能, 肠道菌群代谢物, 宏代谢组

Abstract: Objective To investigate the changes of intestinal microflora metabolites in brain tissue of type 1 diabetes mellitus (T1DM)mice with cognitive impairment. Methods To develop a T1DM model, male C57BL/6 mice aged 6 weeks were given by intraperitoneal injection of STZ at dosage 40 mg/kg of body weight for five consecutive days. The Morris water maze test was used to assess learning and memory ability in mice. An ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) system was applied to identify and quantify microbiota-derived metabolites in brain samples collected from sacrificed mice. Results The gut microbial metabolic profiles in brains of diabetes mellitus (DM) mice differed significantly from controls. Compared with control mice, brain levels of glutamine (Log2FC=0.262,P=0.002), tartaric acid (Log2FC=0.847,P=0.017), lactic acid (Log2FC=0.326,P=0.002) and m-aminobenzoic acid (Log2FC=1.028,P=0.046) were significantly higher (all Log2FC>0, P<0.05) while indolelactic acid, 3-hydroxybutyric acid (Log2FC=-1.466,P=0.049) and other 5 metabolites were significantly lower (all Log2FC<0, P<0.05) in DM mice. Such metabolic differences encompassed pyrimidine metabolism, D-glutamine and D-glutamate metabolism, pyruvate metabolism, purine metabolism and other metabolic pathways. Conclusion Gut microbiome and its metabolites may play a crucial role in the onset and development of type 1 diabetes-induced cognitive impairment. Targeting the gut microbiome and relevant microbiota-derived metabolites would be effective therapeutic treatments for T1DM-induced cognitive impairment.

Key words: type 1 diabetes mellitus, cognitive impairment, microbiota-derived metabolites, Meta-omics

中图分类号: